National Institute of Child Health and Human Development
Maternal-Fetal Medicine Units Network

Publications & Presentations
Factor V Trial

Publications

1. Dizon-Townson D, Miller C, Sibai B, Spong CY, Thom E, Wendel G, Wenstrom K, Samuels P, Cotroneo M, Moawad A, Sorokin Y, Meis P, Miodovnik M, O’Sullivan MJ, Conway D, Wapner RJ, Gabbe SG, for the National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network, Bethesda, Maryland. The relationship of the Factor V Leiden mutation and pregnancy outcomes for mother and fetus. Obstetrics and Gynecology, 106(3): 517-524, 2005.


2. Aagaard-Tillery K, Sibai BM, Spong CY, Momirova V, Wendel G, Wenstrom K, Samuels P, Cotroneo M, Moawad AH, Sorokin Y, Miodovnik M, Meis PJ, O'Sullivan MJ, Conway D, Wapner RJ,for the National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Sample bias among women with retained DNA samples for future genetic studies. Obstetrics and Gynecology, 108:1115-1120, 2006.

Presentations

1. Dizon-Towson D, for the NICHD MFMU Network. The Factor V ledien mutation does not increase risk of pregnancy-related venous thromboembolis. Presented at the 23rd Annual Meeing of the Society for Maternal Fetal Medicine, San Francisco, CA, February 2003.



2. Aagaard-Tillery K for the NICHD MFMU Network. Does granting permission to retain DNA samples for future genetic studies identify a biased population. Presented at the 2005 Annual Meeting of the Society for Gynecologic Investigation, Los Angeles, CA - March 2005.



3. Dizon-Townson D for the NICHD MFMU Network. Impact of smoking during pregnancy and functional coagulation testing. Presented at the 26th Annual Meeting of the Society for Maternal-Fetal Medicine, Miami Beach, FL, January 2006.



4. Sibai Baha for the NICHD MFMU Network. Maternal thrombophillias are not associated with adverse pregnancy outcome (APO): A prospective observational study. Presented at the 26th Annual Meeting of the Society for Maternal-Fetal Medicine, Miami Beach, FL, January 2006.



5. Aagaard-Tillery, K for the NICHD MFMU Network. Pharmocogenomics of maternal tobacco use: Metabolic gene polymorphisms modify risk of adverse pregnancy outcomes. Presented at the 27th Annual Meeting of the Society for Maternal-Fetal Medicine, San Francisco, CA, February 2007.